Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000765:Anesthesia, Conduction; D000772:Anesthesia, Local; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D003315:Cornea / Q000502:physiology; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D004987:Ethers / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006168:Guinea Pigs; D007192:Indenes / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D010042:Ouabain / Q000037:antagonists & inhibitors; D011412:Propanolamines / Q000494:pharmacology* / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D012018:Reflex / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy; D013623:Tail / Q000293:injuries
D000319:Adrenergic beta-Antagonists; D004987:Ethers; D007192:Indenes; D011412:Propanolamines; D010042:Ouabain; D011433:Propranolol; D004837:Epinephrine